AMEX · Financial Statements
Endovia Health Sciences, Inc. (EDVA) Financial Statements
$0.15
AMEX: EDVA
Market Cap $972779
Overview Financials Dividend Endovia Health Sciences, Inc. most recently reported annual revenue of $0, net profit of $-25.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $11.0M $18.0M $19.0M $1.0M $0 Operating Profit $-29.0M $-21.0M $-15.0M $-10.0M $-14.0M Net Profit $-29.0M $-22.0M $-21.0M $-24.0M $-25.0M EPS $-1.02 $-0.53 $-18.95 $-17.68 $-11.97 Op Margin -257.0% -118.0% -81.0% -1236.0% -19416.0%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $16.0M $17.0M $10.0M $3.0M $1.0M Total Liabilities $8.0M $8.0M $16.0M $21.0M $16.0M Cash $4.0M $4.0M $0 $0 $0 Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-15.0M $-14.0M $-10.0M $-7.0M $-5.0M Investing Cash Flow $0 $0 $0 $0 — Financing Cash Flow $19.0M $14.0M $6.0M $8.0M $5.0M Net Cash Flow $4.0M $0 $-4.0M $0 $0 Free Cash Flow $-15.0M $-14.0M $-10.0M $-7.0M $-5.0M
Valuation & Return Ratios
Metric Value PEG Ratio — EV / EBITDA — FCF Yield -487.63% Quick Ratio 0.06 Interest Coverage -4.67 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock